Paget's disease of bone treated with a five day course of oral tiludronate.

Chloro-4-phenyl thiomethylene bisphosphonate (tiludronate) is a new drug which can be used as an inhibitor of bone resorption. As it remains in bone for a long time, and as mineralisation defects have only been seen at doses much higher than those required to decrease osteoclastic activity, it could...

Description complète

Détails bibliographiques

Publié dans:	Ann Rheum Dis
Auteurs principaux:	Reginster, J Y, Lecart, M P, Deroisy, R, Ethgen, D, Zegels, B, Franchimont, P
Format:	Artigo
Langue:	Inglês
Publié:	BMJ Publishing Group 1993
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1004956/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8427515/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.1.54
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!